Signal Bioscience
PrivateLast Round
Accelerator
May 26, 2026
Total Funding Raised
$1.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Signal Bioscience operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was an Accelerator round in May 2026.
Signal Bioscience is a diagnostics and research tools company that develops multiplex polymerase chain reaction (PCR) chemistry technology to expand diagnostic testing capabilities on existing laboratory instruments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signal Bioscience Comparables
Compare Signal Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aplex Bio | 82% | |
| ChromaCode | 78% | |
| PCRassays | 76% |
For institutional investors. Book with your work email.
Signal Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 26, 2026 | ||||
| Pre Seed | Mar 16, 2026 | ||||
| Seed | Mar 16, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Signal Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTools Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 75% MoM, reaching 1.1K.
- May 26, 2026
Received funding from BioTools Innovator.
For institutional investors. Book with your work email.
Signal Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Signal Bioscience's valuation, stock price, and market status.
Is Signal Bioscience a public or private company?
Signal Bioscience is a private company.
What is the current stock price of Signal Bioscience?
Signal Bioscience is a private company, so its shares have no public market price. Caplight tracks Signal Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signal Bioscience worth (valuation)?
Valuation information for Signal Bioscience is not publicly available.
Can I buy Signal Bioscience stock?
Signal Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signal Bioscience's last funding round?
Signal Bioscience's most recent funding round was Accelerator on May 26, 2026.
Who are the main investors in Signal Bioscience?
Key investors in Signal Bioscience include BioTools Innovator.
Will Signal Bioscience IPO soon?
No public IPO plans have been announced for Signal Bioscience.
How can I track Signal Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Signal Bioscience's shares on secondary markets.